Identification	O
of	O
potential	O
predictive	O
markers	O
of	O
dexamethasone	B:C0011777
resistance	O
in	O
childhood	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

Identification	O
of	O
potential	O
predictive	O
markers	O
of	O
dexamethasone	O
resistance	B:C0013203
in	O
childhood	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

Identification	O
of	O
potential	O
predictive	O
markers	O
of	O
dexamethasone	O
resistance	O
in	O
childhood	O
acute	B:C0023449
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

Response	B:C0683154
to	O
dexamethasone	O
(	O
dexamethasone	O
)	O
,	O
as	O
a	O
hallmark	O
drug	I:C1254351
in	O
the	O
treatment	O
of	O
childhood	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
(	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
)	O
,	O
is	O
one	O
of	O
the	O
pivotal	O
prognostic	O
factors	I:C1514474
in	O
the	O
prediction	O
of	I:C0033325
outcome	I:C0033325
in	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

Response	O
to	O
dexamethasone	B:C0011777
(	O
dexamethasone	O
)	O
,	O
as	O
a	O
hallmark	O
drug	I:C1254351
in	O
the	O
treatment	O
of	O
childhood	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
(	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
)	O
,	O
is	O
one	O
of	O
the	O
pivotal	O
prognostic	O
factors	I:C1514474
in	O
the	O
prediction	O
of	I:C0033325
outcome	I:C0033325
in	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

Response	O
to	O
dexamethasone	O
(	O
dexamethasone	B:C0011777
)	O
,	O
as	O
a	O
hallmark	O
drug	I:C1254351
in	O
the	O
treatment	O
of	O
childhood	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
(	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
)	O
,	O
is	O
one	O
of	O
the	O
pivotal	O
prognostic	O
factors	I:C1514474
in	O
the	O
prediction	O
of	I:C0033325
outcome	I:C0033325
in	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

Response	O
to	O
dexamethasone	O
(	O
dexamethasone	O
)	O
,	O
as	O
a	O
hallmark	B:C1254351
drug	I:C1254351
in	O
the	O
treatment	O
of	O
childhood	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
(	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
)	O
,	O
is	O
one	O
of	O
the	O
pivotal	O
prognostic	O
factors	I:C1514474
in	O
the	O
prediction	O
of	I:C0033325
outcome	I:C0033325
in	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

Response	O
to	O
dexamethasone	O
(	O
dexamethasone	O
)	O
,	O
as	O
a	O
hallmark	O
drug	I:C1254351
in	O
the	O
treatment	O
of	O
childhood	O
acute	B:C0023449
lymphoblastic	I:C0023449
leukemia	I:C0023449
(	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
)	O
,	O
is	O
one	O
of	O
the	O
pivotal	O
prognostic	O
factors	I:C1514474
in	O
the	O
prediction	O
of	I:C0033325
outcome	I:C0033325
in	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

Response	O
to	O
dexamethasone	O
(	O
dexamethasone	O
)	O
,	O
as	O
a	O
hallmark	O
drug	I:C1254351
in	O
the	O
treatment	O
of	O
childhood	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
(	O
acute	B:C0023449
lymphoblastic	I:C0023449
leukemia	I:C0023449
)	O
,	O
is	O
one	O
of	O
the	O
pivotal	O
prognostic	O
factors	I:C1514474
in	O
the	O
prediction	O
of	I:C0033325
outcome	I:C0033325
in	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

Response	O
to	O
dexamethasone	O
(	O
dexamethasone	O
)	O
,	O
as	O
a	O
hallmark	O
drug	I:C1254351
in	O
the	O
treatment	O
of	O
childhood	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
(	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
)	O
,	O
is	O
one	O
of	O
the	O
pivotal	O
prognostic	B:C1514474
factors	I:C1514474
in	O
the	O
prediction	O
of	I:C0033325
outcome	I:C0033325
in	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

Response	O
to	O
dexamethasone	O
(	O
dexamethasone	O
)	O
,	O
as	O
a	O
hallmark	O
drug	I:C1254351
in	O
the	O
treatment	O
of	O
childhood	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
(	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
)	O
,	O
is	O
one	O
of	O
the	O
pivotal	O
prognostic	O
factors	I:C1514474
in	O
the	O
prediction	B:C0033325
of	I:C0033325
outcome	I:C0033325
in	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

Response	O
to	O
dexamethasone	O
(	O
dexamethasone	O
)	O
,	O
as	O
a	O
hallmark	O
drug	I:C1254351
in	O
the	O
treatment	O
of	O
childhood	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
(	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
)	O
,	O
is	O
one	O
of	O
the	O
pivotal	O
prognostic	O
factors	I:C1514474
in	O
the	O
prediction	O
of	I:C0033325
outcome	I:C0033325
in	O
acute	B:C0023449
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

Identification	O
of	O
predictive	O
markers	O
of	O
chemoresistance	B:C0013203
is	O
beneficial	O
to	O
selecting	O
of	O
the	O
best	O
therapeutic	O
protocol	I:C0040808
with	O
the	O
lowest	O
effect	O
adverse	I:C0879626
.	O

Identification	O
of	O
predictive	O
markers	O
of	O
chemoresistance	O
is	O
beneficial	O
to	O
selecting	O
of	O
the	O
best	O
therapeutic	B:C0040808
protocol	I:C0040808
with	O
the	O
lowest	O
effect	O
adverse	I:C0879626
.	O

Identification	O
of	O
predictive	O
markers	O
of	O
chemoresistance	O
is	O
beneficial	O
to	O
selecting	O
of	O
the	O
best	O
therapeutic	O
protocol	I:C0040808
with	O
the	O
lowest	O
effect	B:C0879626
adverse	I:C0879626
.	O

Hence	O
,	O
we	O
aimed	O
to	O
find	O
drug	B:C0085104
targets	I:C0085104
using	O
the	O
2DE	O
/	O
MS	O
proteomics	O
study	I:C0022885
of	O
a	O
dexamethasone	O
-	O
resistant	O
cell	I:C0007600
line	I:C0007600
(	O
REH	O
)	O
as	O
a	O
model	O
for	O
poor	O
dexamethasone	O
responding	O
patients	O
before	O
and	O
after	O
drug	O
treatment	I:C0013216
.	O

Hence	O
,	O
we	O
aimed	O
to	O
find	O
drug	O
targets	I:C0085104
using	O
the	O
2DE	B:C0013860
/	O
MS	O
proteomics	O
study	I:C0022885
of	O
a	O
dexamethasone	O
-	O
resistant	O
cell	I:C0007600
line	I:C0007600
(	O
REH	O
)	O
as	O
a	O
model	O
for	O
poor	O
dexamethasone	O
responding	O
patients	O
before	O
and	O
after	O
drug	O
treatment	I:C0013216
.	O

Hence	O
,	O
we	O
aimed	O
to	O
find	O
drug	O
targets	I:C0085104
using	O
the	O
2DE	O
/	O
MS	B:C0037813
proteomics	O
study	I:C0022885
of	O
a	O
dexamethasone	O
-	O
resistant	O
cell	I:C0007600
line	I:C0007600
(	O
REH	O
)	O
as	O
a	O
model	O
for	O
poor	O
dexamethasone	O
responding	O
patients	O
before	O
and	O
after	O
drug	O
treatment	I:C0013216
.	O

Hence	O
,	O
we	O
aimed	O
to	O
find	O
drug	O
targets	I:C0085104
using	O
the	O
2DE	O
/	O
MS	O
proteomics	B:C0022885
study	I:C0022885
of	O
a	O
dexamethasone	O
-	O
resistant	O
cell	I:C0007600
line	I:C0007600
(	O
REH	O
)	O
as	O
a	O
model	O
for	O
poor	O
dexamethasone	O
responding	O
patients	O
before	O
and	O
after	O
drug	O
treatment	I:C0013216
.	O

Hence	O
,	O
we	O
aimed	O
to	O
find	O
drug	O
targets	I:C0085104
using	O
the	O
2DE	O
/	O
MS	O
proteomics	O
study	I:C0022885
of	O
a	O
dexamethasone	B:C0011777
-	O
resistant	O
cell	I:C0007600
line	I:C0007600
(	O
REH	O
)	O
as	O
a	O
model	O
for	O
poor	O
dexamethasone	O
responding	O
patients	O
before	O
and	O
after	O
drug	O
treatment	I:C0013216
.	O

Hence	O
,	O
we	O
aimed	O
to	O
find	O
drug	O
targets	I:C0085104
using	O
the	O
2DE	O
/	O
MS	O
proteomics	O
study	I:C0022885
of	O
a	O
dexamethasone	O
-	O
resistant	B:C0007600
cell	I:C0007600
line	I:C0007600
(	O
REH	O
)	O
as	O
a	O
model	O
for	O
poor	O
dexamethasone	O
responding	O
patients	O
before	O
and	O
after	O
drug	O
treatment	I:C0013216
.	O

Hence	O
,	O
we	O
aimed	O
to	O
find	O
drug	O
targets	I:C0085104
using	O
the	O
2DE	O
/	O
MS	O
proteomics	O
study	I:C0022885
of	O
a	O
dexamethasone	O
-	O
resistant	O
cell	I:C0007600
line	I:C0007600
(	O
REH	B:C0007600
)	O
as	O
a	O
model	O
for	O
poor	O
dexamethasone	O
responding	O
patients	O
before	O
and	O
after	O
drug	O
treatment	I:C0013216
.	O

Hence	O
,	O
we	O
aimed	O
to	O
find	O
drug	O
targets	I:C0085104
using	O
the	O
2DE	O
/	O
MS	O
proteomics	O
study	I:C0022885
of	O
a	O
dexamethasone	O
-	O
resistant	O
cell	I:C0007600
line	I:C0007600
(	O
REH	O
)	O
as	O
a	O
model	O
for	O
poor	O
dexamethasone	B:C0011777
responding	O
patients	O
before	O
and	O
after	O
drug	O
treatment	I:C0013216
.	O

Hence	O
,	O
we	O
aimed	O
to	O
find	O
drug	O
targets	I:C0085104
using	O
the	O
2DE	O
/	O
MS	O
proteomics	O
study	I:C0022885
of	O
a	O
dexamethasone	O
-	O
resistant	O
cell	I:C0007600
line	I:C0007600
(	O
REH	O
)	O
as	O
a	O
model	O
for	O
poor	O
dexamethasone	O
responding	O
patients	O
before	O
and	O
after	O
drug	B:C0013216
treatment	I:C0013216
.	O

Using	O
the	O
proteomic	B:C0022885
methods	I:C0022885
,	O
three	O
differentially	O
expressed	O
proteins	O
were	O
detected	O
,	O
including	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
(	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
)	O
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
(	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
)	O
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
(	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
)	O
.	O

Using	O
the	O
proteomic	O
methods	I:C0022885
,	O
three	O
differentially	O
expressed	B:C1171362
proteins	O
were	O
detected	O
,	O
including	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
(	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
)	O
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
(	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
)	O
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
(	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
)	O
.	O

Using	O
the	O
proteomic	O
methods	I:C0022885
,	O
three	O
differentially	O
expressed	O
proteins	B:C0033684
were	O
detected	O
,	O
including	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
(	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
)	O
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
(	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
)	O
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
(	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
)	O
.	O

Using	O
the	O
proteomic	O
methods	I:C0022885
,	O
three	O
differentially	O
expressed	O
proteins	O
were	O
detected	B:C0442726
,	O
including	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
(	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
)	O
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
(	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
)	O
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
(	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
)	O
.	O

Using	O
the	O
proteomic	O
methods	I:C0022885
,	O
three	O
differentially	O
expressed	O
proteins	O
were	O
detected	O
,	O
including	O
voltage	B:C0753015
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
(	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
)	O
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
(	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
)	O
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
(	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
)	O
.	O

Using	O
the	O
proteomic	O
methods	I:C0022885
,	O
three	O
differentially	O
expressed	O
proteins	O
were	O
detected	O
,	O
including	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
(	O
voltage	B:C0753015
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
)	O
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
(	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
)	O
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
(	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
)	O
.	O

Using	O
the	O
proteomic	O
methods	I:C0022885
,	O
three	O
differentially	O
expressed	O
proteins	O
were	O
detected	O
,	O
including	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
(	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
)	O
,	O
sorting	B:C1741224
Nexin	I:C1741224
3	I:C1741224
(	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
)	O
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
(	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
)	O
.	O

Using	O
the	O
proteomic	O
methods	I:C0022885
,	O
three	O
differentially	O
expressed	O
proteins	O
were	O
detected	O
,	O
including	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
(	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
)	O
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
(	O
sorting	B:C1741224
Nexin	I:C1741224
3	I:C1741224
)	O
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
(	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
)	O
.	O

Using	O
the	O
proteomic	O
methods	I:C0022885
,	O
three	O
differentially	O
expressed	O
proteins	O
were	O
detected	O
,	O
including	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
(	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
)	O
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
(	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
)	O
,	O
and	O
prefoldin	B:C1743484
subunit	I:C1743484
6	I:C1743484
(	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
)	O
.	O

Using	O
the	O
proteomic	O
methods	I:C0022885
,	O
three	O
differentially	O
expressed	O
proteins	O
were	O
detected	O
,	O
including	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
(	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
)	O
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
(	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
)	O
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
(	O
prefoldin	B:C1743484
subunit	I:C1743484
6	I:C1743484
)	O
.	O

We	O
observed	O
low	O
expression	B:C1171362
of	O
three	O
proteins	O
after	O
dexamethasone	O
treatment	O
in	O
REH	O
cells	I:C0007600
.	O

We	O
observed	O
low	O
expression	O
of	O
three	O
proteins	B:C0033684
after	O
dexamethasone	O
treatment	O
in	O
REH	O
cells	I:C0007600
.	O

We	O
observed	O
low	O
expression	O
of	O
three	O
proteins	O
after	O
dexamethasone	B:C0011777
treatment	O
in	O
REH	O
cells	I:C0007600
.	O

We	O
observed	O
low	O
expression	O
of	O
three	O
proteins	O
after	O
dexamethasone	O
treatment	O
in	O
REH	B:C0007600
cells	I:C0007600
.	O

We	O
subsequently	O
verified	O
low	O
expression	B:C1171362
of	O
resulted	O
proteins	O
at	O
the	O
mRNA	O
level	O
using	O
the	O
quantitative	O
PCR	I:C2733022
method	I:C2733022
.	O

We	O
subsequently	O
verified	O
low	O
expression	O
of	O
resulted	O
proteins	B:C0033684
at	O
the	O
mRNA	O
level	O
using	O
the	O
quantitative	O
PCR	I:C2733022
method	I:C2733022
.	O

We	O
subsequently	O
verified	O
low	O
expression	O
of	O
resulted	O
proteins	O
at	O
the	O
mRNA	B:C0035696
level	O
using	O
the	O
quantitative	O
PCR	I:C2733022
method	I:C2733022
.	O

We	O
subsequently	O
verified	O
low	O
expression	O
of	O
resulted	O
proteins	O
at	O
the	O
mRNA	O
level	O
using	O
the	O
quantitative	B:C2733022
PCR	I:C2733022
method	I:C2733022
.	O

These	O
proteins	B:C0033684
are	O
promising	O
proteins	O
because	O
of	O
their	O
important	O
roles	O
in	O
drug	O
resistance	I:C0013203
and	O
regulation	O
of	I:C1148568
apoptosis	I:C1148568
(	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
)	O
,	O
protein	O
trafficking	I:C0599895
(	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
)	O
,	O
and	O
protein	O
folding	I:C0162847
(	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
)	O
.	O

These	O
proteins	O
are	O
promising	O
proteins	B:C0033684
because	O
of	O
their	O
important	O
roles	O
in	O
drug	O
resistance	I:C0013203
and	O
regulation	O
of	I:C1148568
apoptosis	I:C1148568
(	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
)	O
,	O
protein	O
trafficking	I:C0599895
(	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
)	O
,	O
and	O
protein	O
folding	I:C0162847
(	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
)	O
.	O

These	O
proteins	O
are	O
promising	O
proteins	O
because	O
of	O
their	O
important	O
roles	O
in	O
drug	B:C0013203
resistance	I:C0013203
and	O
regulation	O
of	I:C1148568
apoptosis	I:C1148568
(	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
)	O
,	O
protein	O
trafficking	I:C0599895
(	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
)	O
,	O
and	O
protein	O
folding	I:C0162847
(	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
)	O
.	O

These	O
proteins	O
are	O
promising	O
proteins	O
because	O
of	O
their	O
important	O
roles	O
in	O
drug	O
resistance	I:C0013203
and	O
regulation	B:C1148568
of	I:C1148568
apoptosis	I:C1148568
(	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
)	O
,	O
protein	O
trafficking	I:C0599895
(	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
)	O
,	O
and	O
protein	O
folding	I:C0162847
(	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
)	O
.	O

These	O
proteins	O
are	O
promising	O
proteins	O
because	O
of	O
their	O
important	O
roles	O
in	O
drug	O
resistance	I:C0013203
and	O
regulation	O
of	I:C1148568
apoptosis	I:C1148568
(	O
voltage	B:C0753015
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
)	O
,	O
protein	O
trafficking	I:C0599895
(	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
)	O
,	O
and	O
protein	O
folding	I:C0162847
(	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
)	O
.	O

These	O
proteins	O
are	O
promising	O
proteins	O
because	O
of	O
their	O
important	O
roles	O
in	O
drug	O
resistance	I:C0013203
and	O
regulation	O
of	I:C1148568
apoptosis	I:C1148568
(	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
)	O
,	O
protein	B:C0599895
trafficking	I:C0599895
(	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
)	O
,	O
and	O
protein	O
folding	I:C0162847
(	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
)	O
.	O

These	O
proteins	O
are	O
promising	O
proteins	O
because	O
of	O
their	O
important	O
roles	O
in	O
drug	O
resistance	I:C0013203
and	O
regulation	O
of	I:C1148568
apoptosis	I:C1148568
(	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
)	O
,	O
protein	O
trafficking	I:C0599895
(	O
sorting	B:C1741224
Nexin	I:C1741224
3	I:C1741224
)	O
,	O
and	O
protein	O
folding	I:C0162847
(	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
)	O
.	O

These	O
proteins	O
are	O
promising	O
proteins	O
because	O
of	O
their	O
important	O
roles	O
in	O
drug	O
resistance	I:C0013203
and	O
regulation	O
of	I:C1148568
apoptosis	I:C1148568
(	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
)	O
,	O
protein	O
trafficking	I:C0599895
(	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
)	O
,	O
and	O
protein	B:C0162847
folding	I:C0162847
(	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
)	O
.	O

These	O
proteins	O
are	O
promising	O
proteins	O
because	O
of	O
their	O
important	O
roles	O
in	O
drug	O
resistance	I:C0013203
and	O
regulation	O
of	I:C1148568
apoptosis	I:C1148568
(	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
)	O
,	O
protein	O
trafficking	I:C0599895
(	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
)	O
,	O
and	O
protein	O
folding	I:C0162847
(	O
prefoldin	B:C1743484
subunit	I:C1743484
6	I:C1743484
)	O
.	O

Additionally	O
,	O
mRNA	B:C0035696
expression	O
level	O
of	O
these	O
proteins	O
was	O
assessed	O
in	O
17	O
bone	O
marrow	I:C0438737
samples	I:C0438737
from	O
children	O
with	O
newly	O
diagnosed	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
and	O
7	O
non-cancerous	O
samples	O
as	O
controls	O
.	O

Additionally	O
,	O
mRNA	O
expression	O
level	O
of	O
these	O
proteins	B:C0033684
was	O
assessed	O
in	O
17	O
bone	O
marrow	I:C0438737
samples	I:C0438737
from	O
children	O
with	O
newly	O
diagnosed	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
and	O
7	O
non-cancerous	O
samples	O
as	O
controls	O
.	O

Additionally	O
,	O
mRNA	O
expression	O
level	O
of	O
these	O
proteins	O
was	O
assessed	O
in	O
17	O
bone	B:C0438737
marrow	I:C0438737
samples	I:C0438737
from	O
children	O
with	O
newly	O
diagnosed	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
and	O
7	O
non-cancerous	O
samples	O
as	O
controls	O
.	O

Additionally	O
,	O
mRNA	O
expression	O
level	O
of	O
these	O
proteins	O
was	O
assessed	O
in	O
17	O
bone	O
marrow	I:C0438737
samples	I:C0438737
from	O
children	O
with	O
newly	O
diagnosed	O
acute	B:C0023449
lymphoblastic	I:C0023449
leukemia	I:C0023449
and	O
7	O
non-cancerous	O
samples	O
as	O
controls	O
.	O

The	O
results	O
indicated	O
that	O
independent	O
of	O
the	O
molecular	B:C0449560
subtypes	I:C0449560
of	O
leukemia	O
,	O
mRNA	O
expression	O
of	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
decreased	O
in	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
samples	O
compared	O
with	O
non-cancerous	O
samples	O
particularly	O
in	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
(	O
p	O
<	O
0.001	O
)	O
.	O

The	O
results	O
indicated	O
that	O
independent	O
of	O
the	O
molecular	O
subtypes	I:C0449560
of	O
leukemia	B:C0023418
,	O
mRNA	O
expression	O
of	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
decreased	O
in	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
samples	O
compared	O
with	O
non-cancerous	O
samples	O
particularly	O
in	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
(	O
p	O
<	O
0.001	O
)	O
.	O

The	O
results	O
indicated	O
that	O
independent	O
of	O
the	O
molecular	O
subtypes	I:C0449560
of	O
leukemia	O
,	O
mRNA	B:C0035696
expression	O
of	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
decreased	O
in	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
samples	O
compared	O
with	O
non-cancerous	O
samples	O
particularly	O
in	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
(	O
p	O
<	O
0.001	O
)	O
.	O

The	O
results	O
indicated	O
that	O
independent	O
of	O
the	O
molecular	O
subtypes	I:C0449560
of	O
leukemia	O
,	O
mRNA	O
expression	B:C1171362
of	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
decreased	O
in	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
samples	O
compared	O
with	O
non-cancerous	O
samples	O
particularly	O
in	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
(	O
p	O
<	O
0.001	O
)	O
.	O

The	O
results	O
indicated	O
that	O
independent	O
of	O
the	O
molecular	O
subtypes	I:C0449560
of	O
leukemia	O
,	O
mRNA	O
expression	O
of	O
voltage	B:C0753015
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
decreased	O
in	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
samples	O
compared	O
with	O
non-cancerous	O
samples	O
particularly	O
in	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
(	O
p	O
<	O
0.001	O
)	O
.	O

The	O
results	O
indicated	O
that	O
independent	O
of	O
the	O
molecular	O
subtypes	I:C0449560
of	O
leukemia	O
,	O
mRNA	O
expression	O
of	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
,	O
sorting	B:C1741224
Nexin	I:C1741224
3	I:C1741224
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
decreased	O
in	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
samples	O
compared	O
with	O
non-cancerous	O
samples	O
particularly	O
in	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
(	O
p	O
<	O
0.001	O
)	O
.	O

The	O
results	O
indicated	O
that	O
independent	O
of	O
the	O
molecular	O
subtypes	I:C0449560
of	O
leukemia	O
,	O
mRNA	O
expression	O
of	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
,	O
and	O
prefoldin	B:C1743484
subunit	I:C1743484
6	I:C1743484
decreased	O
in	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
samples	O
compared	O
with	O
non-cancerous	O
samples	O
particularly	O
in	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
(	O
p	O
<	O
0.001	O
)	O
.	O

The	O
results	O
indicated	O
that	O
independent	O
of	O
the	O
molecular	O
subtypes	I:C0449560
of	O
leukemia	O
,	O
mRNA	O
expression	O
of	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
decreased	O
in	O
acute	B:C0023449
lymphoblastic	I:C0023449
leukemia	I:C0023449
samples	O
compared	O
with	O
non-cancerous	O
samples	O
particularly	O
in	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
(	O
p	O
<	O
0.001	O
)	O
.	O

The	O
results	O
indicated	O
that	O
independent	O
of	O
the	O
molecular	O
subtypes	I:C0449560
of	O
leukemia	O
,	O
mRNA	O
expression	O
of	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
decreased	O
in	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
samples	O
compared	O
with	O
non-cancerous	O
samples	O
particularly	O
in	O
voltage	B:C0753015
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
(	O
p	O
<	O
0.001	O
)	O
.	O

Additionally	O
,	O
mRNA	B:C0035696
expression	O
of	O
three	O
proteins	O
was	O
also	O
declined	O
in	O
high	O
-	I:C0332167
risk	I:C0332167
samples	O
compared	O
with	O
standard	O
risk	O
cases	O
.	O

Additionally	O
,	O
mRNA	O
expression	B:C1171362
of	O
three	O
proteins	O
was	O
also	O
declined	O
in	O
high	O
-	I:C0332167
risk	I:C0332167
samples	O
compared	O
with	O
standard	O
risk	O
cases	O
.	O

Additionally	O
,	O
mRNA	O
expression	O
of	O
three	O
proteins	B:C0033684
was	O
also	O
declined	O
in	O
high	O
-	I:C0332167
risk	I:C0332167
samples	O
compared	O
with	O
standard	O
risk	O
cases	O
.	O

Additionally	O
,	O
mRNA	O
expression	O
of	O
three	O
proteins	O
was	O
also	O
declined	O
in	O
high	B:C0332167
-	I:C0332167
risk	I:C0332167
samples	O
compared	O
with	O
standard	O
risk	O
cases	O
.	O

These	O
results	O
demonstrated	O
diagnostic	O
and	O
prognostic	B:C0220901
value	O
of	O
these	O
proteins	O
in	O
childhood	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

These	O
results	O
demonstrated	O
diagnostic	O
and	O
prognostic	O
value	O
of	O
these	O
proteins	B:C0033684
in	O
childhood	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

These	O
results	O
demonstrated	O
diagnostic	O
and	O
prognostic	O
value	O
of	O
these	O
proteins	O
in	O
childhood	O
acute	B:C0023449
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

Furthermore	O
,	O
investigation	B:C0220825
of	O
protein	O
-	I:C0872079
protein	I:C0872079
interaction	I:C0872079
using	O
STRING	O
database	O
indicated	O
that	O
these	O
proteins	O
involved	O
in	O
the	O
signaling	O
pathway	I:C0037080
of	O
NR3C1	O
as	O
dexamethasone	O
target	O
.	O

Furthermore	O
,	O
investigation	O
of	O
protein	B:C0872079
-	I:C0872079
protein	I:C0872079
interaction	I:C0872079
using	O
STRING	O
database	O
indicated	O
that	O
these	O
proteins	O
involved	O
in	O
the	O
signaling	O
pathway	I:C0037080
of	O
NR3C1	O
as	O
dexamethasone	O
target	O
.	O

Furthermore	O
,	O
investigation	O
of	O
protein	O
-	I:C0872079
protein	I:C0872079
interaction	I:C0872079
using	O
STRING	B:C1547402
database	O
indicated	O
that	O
these	O
proteins	O
involved	O
in	O
the	O
signaling	O
pathway	I:C0037080
of	O
NR3C1	O
as	O
dexamethasone	O
target	O
.	O

Furthermore	O
,	O
investigation	O
of	O
protein	O
-	I:C0872079
protein	I:C0872079
interaction	I:C0872079
using	O
STRING	O
database	B:C0242356
indicated	O
that	O
these	O
proteins	O
involved	O
in	O
the	O
signaling	O
pathway	I:C0037080
of	O
NR3C1	O
as	O
dexamethasone	O
target	O
.	O

Furthermore	O
,	O
investigation	O
of	O
protein	O
-	I:C0872079
protein	I:C0872079
interaction	I:C0872079
using	O
STRING	O
database	O
indicated	O
that	O
these	O
proteins	B:C0033684
involved	O
in	O
the	O
signaling	O
pathway	I:C0037080
of	O
NR3C1	O
as	O
dexamethasone	O
target	O
.	O

Furthermore	O
,	O
investigation	O
of	O
protein	O
-	I:C0872079
protein	I:C0872079
interaction	I:C0872079
using	O
STRING	O
database	O
indicated	O
that	O
these	O
proteins	O
involved	O
in	O
the	O
signaling	B:C0037080
pathway	I:C0037080
of	O
NR3C1	O
as	O
dexamethasone	O
target	O
.	O

Furthermore	O
,	O
investigation	O
of	O
protein	O
-	I:C0872079
protein	I:C0872079
interaction	I:C0872079
using	O
STRING	O
database	O
indicated	O
that	O
these	O
proteins	O
involved	O
in	O
the	O
signaling	O
pathway	I:C0037080
of	O
NR3C1	B:C1370369
as	O
dexamethasone	O
target	O
.	O

Furthermore	O
,	O
investigation	O
of	O
protein	O
-	I:C0872079
protein	I:C0872079
interaction	I:C0872079
using	O
STRING	O
database	O
indicated	O
that	O
these	O
proteins	O
involved	O
in	O
the	O
signaling	O
pathway	I:C0037080
of	O
NR3C1	O
as	O
dexamethasone	B:C0011777
target	O
.	O

Furthermore	O
,	O
investigation	O
of	O
protein	O
-	I:C0872079
protein	I:C0872079
interaction	I:C0872079
using	O
STRING	O
database	O
indicated	O
that	O
these	O
proteins	O
involved	O
in	O
the	O
signaling	O
pathway	I:C0037080
of	O
NR3C1	O
as	O
dexamethasone	O
target	B:C0243095
.	O

In	O
conclusion	O
,	O
our	O
proteomic	B:C0022885
study	I:C0022885
in	O
dexamethasone	O
resistant	O
leukemic	O
cells	I:C1517806
revealed	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
are	O
promising	O
proteins	O
that	O
might	O
serve	O
as	O
potential	O
biomarkers	O
of	O
prognosis	O
and	O
chemotherapy	O
in	O
childhood	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

In	O
conclusion	O
,	O
our	O
proteomic	O
study	I:C0022885
in	O
dexamethasone	B:C0011777
resistant	O
leukemic	O
cells	I:C1517806
revealed	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
are	O
promising	O
proteins	O
that	O
might	O
serve	O
as	O
potential	O
biomarkers	O
of	O
prognosis	O
and	O
chemotherapy	O
in	O
childhood	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

In	O
conclusion	O
,	O
our	O
proteomic	O
study	I:C0022885
in	O
dexamethasone	O
resistant	B:C0013203
leukemic	O
cells	I:C1517806
revealed	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
are	O
promising	O
proteins	O
that	O
might	O
serve	O
as	O
potential	O
biomarkers	O
of	O
prognosis	O
and	O
chemotherapy	O
in	O
childhood	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

In	O
conclusion	O
,	O
our	O
proteomic	O
study	I:C0022885
in	O
dexamethasone	O
resistant	O
leukemic	B:C1517806
cells	I:C1517806
revealed	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
are	O
promising	O
proteins	O
that	O
might	O
serve	O
as	O
potential	O
biomarkers	O
of	O
prognosis	O
and	O
chemotherapy	O
in	O
childhood	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

In	O
conclusion	O
,	O
our	O
proteomic	O
study	I:C0022885
in	O
dexamethasone	O
resistant	O
leukemic	O
cells	I:C1517806
revealed	O
voltage	B:C0753015
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
are	O
promising	O
proteins	O
that	O
might	O
serve	O
as	O
potential	O
biomarkers	O
of	O
prognosis	O
and	O
chemotherapy	O
in	O
childhood	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

In	O
conclusion	O
,	O
our	O
proteomic	O
study	I:C0022885
in	O
dexamethasone	O
resistant	O
leukemic	O
cells	I:C1517806
revealed	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
,	O
sorting	B:C1741224
Nexin	I:C1741224
3	I:C1741224
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
are	O
promising	O
proteins	O
that	O
might	O
serve	O
as	O
potential	O
biomarkers	O
of	O
prognosis	O
and	O
chemotherapy	O
in	O
childhood	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

In	O
conclusion	O
,	O
our	O
proteomic	O
study	I:C0022885
in	O
dexamethasone	O
resistant	O
leukemic	O
cells	I:C1517806
revealed	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
,	O
and	O
prefoldin	B:C1743484
subunit	I:C1743484
6	I:C1743484
are	O
promising	O
proteins	O
that	O
might	O
serve	O
as	O
potential	O
biomarkers	O
of	O
prognosis	O
and	O
chemotherapy	O
in	O
childhood	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

In	O
conclusion	O
,	O
our	O
proteomic	O
study	I:C0022885
in	O
dexamethasone	O
resistant	O
leukemic	O
cells	I:C1517806
revealed	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
are	O
promising	O
proteins	B:C0033684
that	O
might	O
serve	O
as	O
potential	O
biomarkers	O
of	O
prognosis	O
and	O
chemotherapy	O
in	O
childhood	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

In	O
conclusion	O
,	O
our	O
proteomic	O
study	I:C0022885
in	O
dexamethasone	O
resistant	O
leukemic	O
cells	I:C1517806
revealed	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
are	O
promising	O
proteins	O
that	O
might	O
serve	O
as	O
potential	O
biomarkers	B:C0005516
of	O
prognosis	O
and	O
chemotherapy	O
in	O
childhood	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

In	O
conclusion	O
,	O
our	O
proteomic	O
study	I:C0022885
in	O
dexamethasone	O
resistant	O
leukemic	O
cells	I:C1517806
revealed	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
are	O
promising	O
proteins	O
that	O
might	O
serve	O
as	O
potential	O
biomarkers	O
of	O
prognosis	B:C0033325
and	O
chemotherapy	O
in	O
childhood	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

In	O
conclusion	O
,	O
our	O
proteomic	O
study	I:C0022885
in	O
dexamethasone	O
resistant	O
leukemic	O
cells	I:C1517806
revealed	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
are	O
promising	O
proteins	O
that	O
might	O
serve	O
as	O
potential	O
biomarkers	O
of	O
prognosis	O
and	O
chemotherapy	B:C3665472
in	O
childhood	O
acute	O
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

In	O
conclusion	O
,	O
our	O
proteomic	O
study	I:C0022885
in	O
dexamethasone	O
resistant	O
leukemic	O
cells	I:C1517806
revealed	O
voltage	O
dependent	I:C0753015
anion	I:C0753015
channel	I:C0753015
1	I:C0753015
,	O
sorting	O
Nexin	I:C1741224
3	I:C1741224
,	O
and	O
prefoldin	O
subunit	I:C1743484
6	I:C1743484
are	O
promising	O
proteins	O
that	O
might	O
serve	O
as	O
potential	O
biomarkers	O
of	O
prognosis	O
and	O
chemotherapy	O
in	O
childhood	O
acute	B:C0023449
lymphoblastic	I:C0023449
leukemia	I:C0023449
.	O

